Overview

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether THERATOPE vaccine therapy is more effective than standard vaccine therapy in treating metastatic breast cancer. PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of THERATOPE vaccine therapy with that of standard vaccine therapy in treating women who have metastatic breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Oncothyreon Canada Inc.
Treatments:
Cyclophosphamide
Detox adjuvant
Keyhole-limpet hemocyanin
Vaccines